Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sabra Healthcare REIT Inc shares valued at $23,880 were purchased by Cusack Catherine on Feb 24 ’25. At $15.92 per share, Cusack Catherine acquired 1,500 shares. The insider’s holdings grew to 60,583 shares worth approximately $1.04 million following the completion of this transaction.
Also, Cusack Catherine purchased 1,000 shares, netting a total of over 16,435 in proceeds. Following the buying of shares at $16.43 each, the insider now holds 59,083 shares.
Before that, Cusack Catherine had added 7,000 shares to its account. In a trade valued at $101,010, the Director bought Sabra Healthcare REIT Inc shares for $14.43 each. Upon closing the transaction, the insider’s holdings increased to 7,000 shares, worth approximately $0.79 million.
As published in a research note from Truist on January 17, 2025, Sabra Healthcare REIT Inc [SBRA] has been rated down from a Buy to a Hold. Analysts at JMP Securities upgraded the stock from ‘”a Mkt perform”‘ to ‘”a Mkt outperform”‘ outlook in a report released in early January. As of December 05, 2024, Mizuho has decreased its “an Outperform” rating to a “Neutral” for SBRA. Earlier on October 01, 2024, Wells Fargo upgraded its rating. Their new recommendation was “an Overweight” for SBRA stock which previously was a “an Equal weight”.
Analyzing SBRA Stock Performance
During the last five days, there has been a surge of approximately 4.27%. Over the course of the year, Sabra Healthcare REIT Inc shares have dropped approximately -1.33%. Shares of the company reached a 52-week high of $17.49 on 01/28/25 and a 52-week low of $15.60 on 02/21/25. A 50-day SMA is recorded $16.76, while a 200-day SMA reached $16.92.
Support And Resistance Levels for Sabra Healthcare REIT Inc (SBRA)
According to the 24-hour chart, there is a support level at 16.82, which, if violated, would cause prices to drop to 16.54. In the upper region, resistance lies at 17.34. The next price resistance is at 17.58. RSI (Relative Strength Index) is 58.33 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.46, which suggests the price will decrease in the coming days. Percent R is at 12.83%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
